National, state and territory trends in gestational diabetes mellitus in Australia, 2016-2021: Differences by state/territory and country of birth
View abstract on PubMed
Summary
This summary is machine-generated.Gestational diabetes mellitus (GDM) incidence increased significantly across Australia from 2016 to 2021, with the highest rises observed in the Northern Territory and among Southeast Asian-born women. Culturally tailored prevention strategies are urgently needed.
Area Of Science
- Public Health
- Epidemiology
- Reproductive Health
Background
- Gestational diabetes mellitus (GDM) poses significant risks to maternal and infant health.
- Understanding GDM trends is crucial for effective public health interventions.
- Australia has diverse demographics requiring localized GDM management strategies.
Purpose Of The Study
- To investigate the trends of gestational diabetes mellitus (GDM) incidence in Australia.
- To analyze GDM trends by state/territory and country of birth.
- To identify specific populations experiencing significant increases in GDM.
Main Methods
- A cross-sectional study utilized data from the National Diabetes Services Scheme (NDSS) and Australian Bureau of Statistics from 2016 to 2021.
- Average Annual Percentage Changes (AAPCs) were calculated to assess trend magnitudes.
- The Cochrane-Armitage test was employed for trend assessment.
Main Results
- Nationally, age-standardised GDM incidence rose from 9.3% in 2016 to 15.7% in 2021 (AAPC +10.9%).
- The Northern Territory showed the most substantial increase, from 6.7% to 19.2% (AAPC +24.6%).
- Women born in Southeast Asia experienced a rise in GDM incidence from 12.2% to 22.5% (p-trend <0.001).
Conclusions
- GDM incidence has significantly increased across Australia, with notable rises in the Northern Territory and Victoria.
- Women born in Southeast Asia, and South and Central Asia are disproportionately affected.
- There is an urgent need for location-specific and culturally sensitive GDM prevention programs.
Related Concept Videos
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...

